Atticus Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Atticus Wealth Management's PFE Position: Q3 2025 in Review
Atticus Wealth Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 362 shares — an estimated $8.78K sold.
Atticus Wealth Management first reported a position in PFE in Q4 2019 and held it in 23 quarters. The position peaked at $447K in Q4 2022. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Atticus Wealth Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Atticus Wealth Management sold 362 Pfizer shares in Q3 2025, an estimated $8.78K.
- Atticus Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 23 quarters.
- Atticus Wealth Management's Pfizer position peaked at $447K in Q4 2022.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Atticus Wealth Management's 13F filing for Q3 2025, filed 7 Nov 2025.